6-31356856-T-C

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4

The NM_005514.8(HLA-B):​c.175A>G​(p.Arg59Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000918 in 1,089,908 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.0 ( 0 hom., cov: 9)
Exomes 𝑓: 9.2e-7 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

HLA-B
NM_005514.8 missense

Scores

2
2
13

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.221

Publications

5 publications found
Variant links:
Genes affected
HLA-B (HGNC:4932): (major histocompatibility complex, class I, B) HLA-B belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exon 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. Hundreds of HLA-B alleles have been described. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.37735406).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HLA-BNM_005514.8 linkc.175A>G p.Arg59Gly missense_variant Exon 2 of 8 ENST00000412585.7 NP_005505.2 P01889E5FQ95

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HLA-BENST00000412585.7 linkc.175A>G p.Arg59Gly missense_variant Exon 2 of 8 6 NM_005514.8 ENSP00000399168.2 P01889

Frequencies

GnomAD3 genomes
AF:
0.00
AC:
0
AN:
67994
Hom.:
0
Cov.:
9
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00
AC:
0
AN:
226310
AF XY:
0.00
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
9.18e-7
AC:
1
AN:
1089908
Hom.:
0
Cov.:
27
AF XY:
0.00000184
AC XY:
1
AN XY:
542272
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
23304
American (AMR)
AF:
0.00
AC:
0
AN:
33342
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
21402
East Asian (EAS)
AF:
0.00
AC:
0
AN:
26588
South Asian (SAS)
AF:
0.00
AC:
0
AN:
58780
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
35856
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3096
European-Non Finnish (NFE)
AF:
0.00000119
AC:
1
AN:
842474
Other (OTH)
AF:
0.00
AC:
0
AN:
45066
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.225
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Data not reliable, filtered out with message: AC0
AF:
0.00
AC:
0
AN:
67994
Hom.:
0
Cov.:
9
AF XY:
0.00
AC XY:
0
AN XY:
32126
African (AFR)
AF:
0.00
AC:
0
AN:
17146
American (AMR)
AF:
0.00
AC:
0
AN:
6384
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2054
East Asian (EAS)
AF:
0.00
AC:
0
AN:
1568
South Asian (SAS)
AF:
0.00
AC:
0
AN:
1274
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
4700
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
152
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
33530
Other (OTH)
AF:
0.00
AC:
0
AN:
798

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Uncertain
0.044
T
BayesDel_noAF
Benign
-0.17
CADD
Benign
23
DANN
Benign
0.95
DEOGEN2
Benign
0.019
T;.;T
Eigen
Benign
-0.64
Eigen_PC
Benign
-0.81
FATHMM_MKL
Benign
0.026
N
LIST_S2
Benign
0.20
T;T;T
M_CAP
Benign
0.0092
T
MetaRNN
Benign
0.38
T;T;T
MetaSVM
Benign
-0.95
T
PhyloP100
-0.22
PROVEAN
Pathogenic
-5.4
D;.;D
REVEL
Benign
0.19
Sift
Pathogenic
0.0
D;.;D
Sift4G
Uncertain
0.040
D;.;D
Polyphen
0.62
P;.;.
Vest4
0.33
MutPred
0.64
Gain of catalytic residue at F60 (P = 0.0488);Gain of catalytic residue at F60 (P = 0.0488);.;
MVP
0.17
MPC
0.48
ClinPred
0.73
D
GERP RS
1.2
PromoterAI
-0.036
Neutral
Varity_R
0.78
gMVP
0.34
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1065378; hg19: chr6-31324633; API